|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Structure
1:83-93
(1993)
|
|
PubMed id:
|
|
|
|
|
| |
|
Major antigen-induced domain rearrangements in an antibody.
|
|
R.L.Stanfield,
M.Takimoto-Kamimura,
J.M.Rini,
A.T.Profy,
I.A.Wilson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Recent structural results have shown that antibodies use an induced
fit mechanism to recognize and bind their antigens. Here we present the
crystallographically determined structure of an Fab directed against an HIV-1
peptide (Fab 50.1) in the unliganded state and compare it with the peptide-bound
structure. We perform a detailed analysis of the components that contribute to
enhanced antigen binding and recognition. RESULTS: Induced fit of Fab 50.1 to
its peptide antigen involves a substantial rearrangement of the third
complementarity determining region loop of the heavy chain (H3), as well as a
large rotation of the variable heavy (VH) chain relative to the variable light
(VL) chain. Analysis of other Fab structures suggests that the extent of the
surface area buried at the VL-VH interface correlates with the ability to alter
antibody quaternary structure by reorientation of the VL-VH domains. CONCLUSION:
Fab 50.1 exhibits the largest conformational changes yet observed in a single
antibody. These can be attributed to the flexibility of the variable region.
Comparisons of new data with previous examples lend to the general conclusion
that a small VL-VH interface, due in part to a short H3 loop, permits
substantial alterations to the antigen-binding pocket. This has major
implications for the prediction, engineering and design of antibody-combining
sites.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Sivasubramanian,
A.Sircar,
S.Chaudhury,
and
J.J.Gray
(2009).
Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking.
|
| |
Proteins,
74,
497-514.
|
 |
|
|
|
|
 |
R.Hernandez,
and
A.Paredes
(2009).
Sindbis virus as a model for studies of conformational changes in a metastable virus and the role of conformational changes in in vitro antibody neutralisation.
|
| |
Rev Med Virol,
19,
257-272.
|
 |
|
|
|
|
 |
A.K.Dhillon,
R.L.Stanfield,
M.K.Gorny,
C.Williams,
S.Zolla-Pazner,
and
I.A.Wilson
(2008).
Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
792-802.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.May,
and
M.Zacharias
(2008).
Energy minimization in low-frequency normal modes to efficiently allow for global flexibility during systematic protein-protein docking.
|
| |
Proteins,
70,
794-809.
|
 |
|
|
|
|
 |
C.McBeth,
A.Seamons,
J.C.Pizarro,
S.J.Fleishman,
D.Baker,
T.Kortemme,
J.M.Goverman,
and
R.K.Strong
(2008).
A new twist in TCR diversity revealed by a forbidden alphabeta TCR.
|
| |
J Mol Biol,
375,
1306-1319.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Kuroda,
H.Shirai,
M.Kobori,
and
H.Nakamura
(2008).
Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
|
| |
Proteins,
73,
608-620.
|
 |
|
|
|
|
 |
J.E.Lee,
A.Kuehne,
D.M.Abelson,
M.L.Fusco,
M.K.Hart,
and
E.O.Saphire
(2008).
Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.
|
| |
J Mol Biol,
375,
202-216.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.D.Silverman
(2007).
Using molecular principal axes for structural comparison: determining the tertiary changes of a FAB antibody domain induced by antigenic binding.
|
| |
BMC Struct Biol,
7,
77.
|
 |
|
|
|
|
 |
K.Masuda,
K.Sakamoto,
M.Kojima,
T.Aburatani,
T.Ueda,
and
H.Ueda
(2006).
The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
|
| |
FEBS J,
273,
2184-2194.
|
 |
|
|
|
|
 |
M.Geva,
M.Eisenstein,
and
L.Addadi
(2004).
Antibody recognition of chiral surfaces. Structural models of antibody complexes with leucine-leucine-tyrosine crystal surfaces.
|
| |
Proteins,
55,
862-873.
|
 |
|
|
|
|
 |
E.Vargas-Madrazo,
and
E.Paz-García
(2003).
An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues.
|
| |
J Mol Recognit,
16,
113-120.
|
 |
|
|
|
|
 |
G.J.Kroon,
H.Mo,
M.A.Martinez-Yamout,
H.J.Dyson,
and
P.E.Wright
(2003).
Changes in structure and dynamics of the Fv fragment of a catalytic antibody upon binding of inhibitor.
|
| |
Protein Sci,
12,
1386-1394.
|
 |
|
|
|
|
 |
I.Kumagai,
Y.Nishimiya,
H.Kondo,
and
K.Tsumoto
(2003).
Structural consequences of target epitope-directed functional alteration of an antibody. The case of anti-hen lysozyme antibody, HyHEL-10.
|
| |
J Biol Chem,
278,
24929-24936.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Mohan,
N.Sinha,
and
S.J.Smith-Gill
(2003).
Modeling the binding sites of anti-hen egg white lysozyme antibodies HyHEL-8 and HyHEL-26: an insight into the molecular basis of antibody cross-reactivity and specificity.
|
| |
Biophys J,
85,
3221-3236.
|
 |
|
|
|
|
 |
X.Zhu,
N.A.Larsen,
A.Basran,
N.C.Bruce,
and
I.A.Wilson
(2003).
Observation of an arsenic adduct in an acetyl esterase crystal structure.
|
| |
J Biol Chem,
278,
2008-2014.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.P.Campbell,
W.Y.Wong,
R.T.Irvin,
and
B.D.Sykes
(2000).
Interaction of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: conformation of the bound peptide.
|
| |
Biochemistry,
39,
14847-14864.
|
 |
|
|
|
|
 |
B.C.Braden,
F.A.Goldbaum,
B.X.Chen,
A.N.Kirschner,
S.R.Wilson,
and
B.F.Erlanger
(2000).
X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60).
|
| |
Proc Natl Acad Sci U S A,
97,
12193-12197.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Sotriffer,
B.M.Rode,
J.M.Varga,
and
K.R.Liedl
(2000).
Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: large effects of a small hapten.
|
| |
Biophys J,
79,
614-628.
|
 |
|
|
|
|
 |
E.J.Sundberg,
and
R.A.Mariuzza
(2000).
Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions.
|
| |
Structure,
8,
R137-R142.
|
 |
|
|
|
|
 |
J.Kleinjung,
M.C.Petit,
P.Orlewski,
A.Mamalaki,
S.J.Tzartos,
V.Tsikaris,
M.Sakarellos-Daitsiotis,
C.Sakarellos,
M.Marraud,
and
M.T.Cung
(2000).
The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
|
| |
Biopolymers,
53,
113-128.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Spendlove,
L.Li,
V.Potter,
D.Christiansen,
B.E.Loveland,
and
L.G.Durrant
(2000).
A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
|
| |
Eur J Immunol,
30,
2944-2953.
|
 |
|
|
|
|
 |
P.B.Furtado,
R.Furmonaviciene,
J.McElveen,
H.F.Sewell,
and
F.Shakib
(2000).
Prediction of the interacting surfaces in a trimolecular complex formed between the major dust mite allergen Der p 1, a mouse monoclonal anti-Der p 1 antibody, and its anti-idiotype.
|
| |
Mol Pathol,
53,
324-332.
|
 |
|
|
|
|
 |
S.Monaco-Malbet,
C.Berthet-Colominas,
A.Novelli,
N.Battaï,
N.Piga,
V.Cheynet,
F.Mallet,
and
S.Cusack
(2000).
Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
|
| |
Structure,
8,
1069-1077.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.J.Boniface,
Z.Reich,
D.S.Lyons,
and
M.M.Davis
(1999).
Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning.
|
| |
Proc Natl Acad Sci U S A,
96,
11446-11451.
|
 |
|
|
|
|
 |
J.L.Pellequer,
S.Chen,
V.A.Roberts,
J.A.Tainer,
and
E.D.Getzoff
(1999).
Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
|
| |
J Mol Recognit,
12,
267-275.
|
 |
|
|
|
|
 |
K.C.Garcia,
L.Teyton,
and
I.A.Wilson
(1999).
Structural basis of T cell recognition.
|
| |
Annu Rev Immunol,
17,
369-397.
|
 |
|
|
|
|
 |
K.C.Garcia
(1999).
Molecular interactions between extracellular components of the T-cell receptor signaling complex.
|
| |
Immunol Rev,
172,
73-85.
|
 |
|
|
|
|
 |
M.J.Kaminski,
C.R.MacKenzie,
M.J.Mooibroek,
T.E.Dahms,
T.Hirama,
A.N.Houghton,
P.B.Chapman,
and
S.V.Evans
(1999).
The role of homophilic binding in anti-tumor antibody R24 recognition of molecular surfaces. Demonstration of an intermolecular beta-sheet interaction between vh domains.
|
| |
J Biol Chem,
274,
5597-5604.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Stanfield,
E.Cabezas,
A.Satterthwait,
E.Stura,
A.Profy,
and
I.Wilson
(1999).
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.
|
| |
Structure,
7,
131-142.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Kumar,
B.Ma,
C.J.Tsai,
H.Wolfson,
and
R.Nussinov
(1999).
Folding funnels and conformational transitions via hinge-bending motions.
|
| |
Cell Biochem Biophys,
31,
141-164.
|
 |
|
|
|
|
 |
T.Kieber-Emmons,
C.Lin,
M.H.Foster,
and
T.R.Kleyman
(1999).
Antiidiotypic antibody recognizes an amiloride binding domain within the alpha subunit of the epithelial Na+ channel.
|
| |
J Biol Chem,
274,
9648-9655.
|
 |
|
|
|
|
 |
E.J.Collins,
and
J.A.Frelinger
(1998).
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes.
|
| |
Immunol Rev,
163,
151-160.
|
 |
|
|
|
|
 |
J.Wang,
K.Lim,
A.Smolyar,
M.Teng,
J.Liu,
A.G.Tse,
J.Liu,
R.E.Hussey,
Y.Chishti,
C.T.Thomson,
R.M.Sweet,
S.G.Nathenson,
H.C.Chang,
J.C.Sacchettini,
and
E.L.Reinherz
(1998).
Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody.
|
| |
EMBO J,
17,
10-26.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.C.Garcia,
M.Degano,
L.R.Pease,
M.Huang,
P.A.Peterson,
L.Teyton,
and
I.A.Wilson
(1998).
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.
|
| |
Science,
279,
1166-1172.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.M.Arndt,
K.M.Müller,
and
A.Plückthun
(1998).
Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
|
| |
Biochemistry,
37,
12918-12926.
|
 |
|
|
|
|
 |
X.Ysern,
H.Li,
and
R.A.Mariuzza
(1998).
Imperfect interfaces.
|
| |
Nat Struct Biol,
5,
412-414.
|
 |
|
|
|
|
 |
Y.Ghendler,
A.Smolyar,
H.C.Chang,
and
E.L.Reinherz
(1998).
One of the CD3epsilon subunits within a T cell receptor complex lies in close proximity to the Cbeta FG loop.
|
| |
J Exp Med,
187,
1529-1536.
|
 |
|
|
|
|
 |
B.Gigant,
J.B.Charbonnier,
Z.Eshhar,
B.S.Green,
and
M.Knossow
(1997).
X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release.
|
| |
Proc Natl Acad Sci U S A,
94,
7857-7861.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.H.Trinh,
S.D.Hemmington,
M.E.Verhoeyen,
and
S.E.Phillips
(1997).
Antibody fragment Fv4155 bound to two closely related steroid hormones: the structural basis of fine specificity.
|
| |
Structure,
5,
937-948.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.B.Smithrud,
and
S.J.Benkovic
(1997).
The state of antibody catalysis.
|
| |
Curr Opin Biotechnol,
8,
459-466.
|
 |
|
|
|
|
 |
I.A.Wilson,
and
K.C.Garcia
(1997).
T-cell receptor structure and TCR complexes.
|
| |
Curr Opin Struct Biol,
7,
839-848.
|
 |
|
|
|
|
 |
L.J.Harris,
S.B.Larson,
K.W.Hasel,
and
A.McPherson
(1997).
Refined structure of an intact IgG2a monoclonal antibody.
|
| |
Biochemistry,
36,
1581-1597.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.W.Guddat,
J.C.Bardwell,
T.Zander,
and
J.L.Martin
(1997).
The uncharged surface features surrounding the active site of Escherichia coli DsbA are conserved and are implicated in peptide binding.
|
| |
Protein Sci,
6,
1148-1156.
|
 |
|
|
|
|
 |
M.J.Banfield,
D.J.King,
A.Mountain,
and
R.L.Brady
(1997).
VL:VH domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs.
|
| |
Proteins,
29,
161-171.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Keitel,
A.Kramer,
H.Wessner,
C.Scholz,
J.Schneider-Mergener,
and
W.Höhne
(1997).
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity.
|
| |
Cell,
91,
811-820.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Y.Pei,
P.Holliger,
A.G.Murzin,
and
R.L.Williams
(1997).
The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.
|
| |
Proc Natl Acad Sci U S A,
94,
9637-9642.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Desmyter,
T.R.Transue,
M.A.Ghahroudi,
M.H.Thi,
F.Poortmans,
R.Hamers,
S.Muyldermans,
and
L.Wyns
(1996).
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme.
|
| |
Nat Struct Biol,
3,
803-811.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.B.Huang,
C.F.Ainsworth,
F.J.Stevens,
and
M.Schiffer
(1996).
Three quaternary structures for a single protein.
|
| |
Proc Natl Acad Sci U S A,
93,
7017-7021.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.R.Davies,
and
G.H.Cohen
(1996).
Interactions of protein antigens with antibodies.
|
| |
Proc Natl Acad Sci U S A,
93,
7.
|
 |
|
|
|
|
 |
J.D.Fontenot,
V.R.Zacharopoulos,
and
D.M.Phillips
(1996).
Proline-rich tandem repeats of antibody complementarity-determining regions bind and neutralize human immunodeficiency virus type 1 particles.
|
| |
J Virol,
70,
6557-6562.
|
 |
|
|
|
|
 |
R.L.Markert,
H.Ruppach,
S.Gehring,
U.Dietrich,
D.F.Mierke,
M.Köck,
H.Rübsamen-Waigmann,
and
C.Griesinger
(1996).
Secondary structural elements as a basis for antibody recognition in the immunodominant region of human immunodeficiency viruses 1 and 2.
|
| |
Eur J Biochem,
237,
188-204.
|
 |
|
|
|
|
 |
S.Jones,
and
J.M.Thornton
(1996).
Principles of protein-protein interactions.
|
| |
Proc Natl Acad Sci U S A,
93,
13-20.
|
 |
|
|
|
|
 |
G.Siligardi,
and
A.F.Drake
(1995).
The importance of extended conformations and, in particular, the PII conformation for the molecular recognition of peptides.
|
| |
Biopolymers,
37,
281-292.
|
 |
|
|
|
|
 |
I.M.Tomlinson,
J.P.Cox,
E.Gherardi,
A.M.Lesk,
and
C.Chothia
(1995).
The structural repertoire of the human V kappa domain.
|
| |
EMBO J,
14,
4628-4638.
|
 |
|
|
|
|
 |
J.Bajorath,
L.Harris,
and
J.Novotny
(1995).
Conformational similarity and systematic displacement of complementarity determining region loops in high resolution antibody x-ray structures.
|
| |
J Biol Chem,
270,
22081-22084.
|
 |
|
|
|
|
 |
M.W.Wien,
D.J.Filman,
E.A.Stura,
S.Guillot,
F.Delpeyroux,
R.Crainic,
and
J.M.Hogle
(1995).
Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope.
|
| |
Nat Struct Biol,
2,
232-243.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.L.Stanfield,
and
I.A.Wilson
(1995).
Protein-peptide interactions.
|
| |
Curr Opin Struct Biol,
5,
103-113.
|
 |
|
|
|
|
 |
B.Golinelli-Pimpaneau,
B.Gigant,
T.Bizebard,
J.Navaza,
P.Saludjian,
R.Zemel,
D.S.Tawfik,
Z.Eshhar,
B.S.Green,
and
M.Knossow
(1994).
Crystal structure of a catalytic antibody Fab with esterase-like activity.
|
| |
Structure,
2,
175-183.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Janeway
(1994).
Thymic selection: two pathways to life and two to death.
|
| |
Immunity,
1,
3-6.
|
 |
|
|
|
|
 |
C.F.Barbas,
D.Hu,
N.Dunlop,
L.Sawyer,
D.Cababa,
R.M.Hendry,
P.L.Nara,
and
D.R.Burton
(1994).
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.
|
| |
Proc Natl Acad Sci U S A,
91,
3809-3813.
|
 |
|
|
|
|
 |
D.J.Kenan,
D.E.Tsai,
and
J.D.Keene
(1994).
Exploring molecular diversity with combinatorial shape libraries.
|
| |
Trends Biochem Sci,
19,
57-64.
|
 |
|
|
|
|
 |
I.A.Wilson,
and
R.L.Stanfield
(1994).
Antibody-antigen interactions: new structures and new conformational changes.
|
| |
Curr Opin Struct Biol,
4,
857-867.
|
 |
|
|
|
|
 |
J.Tormo,
D.Blaas,
N.R.Parry,
D.Rowlands,
D.Stuart,
and
I.Fita
(1994).
Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2.
|
| |
EMBO J,
13,
2247-2256.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.M.Colman
(1994).
Influenza virus neuraminidase: structure, antibodies, and inhibitors.
|
| |
Protein Sci,
3,
1687-1696.
|
 |
|
|
|
|
 |
R.L.Stanfield,
and
I.A.Wilson
(1994).
Antigen-induced conformational changes in antibodies: a problem for structural prediction and design.
|
| |
Trends Biotechnol,
12,
275-279.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |